These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 29329228)

  • 1. Current NMR Techniques for Structure-Based Drug Discovery.
    Sugiki T; Furuita K; Fujiwara T; Kojima C
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes.
    Dias DM; Ciulli A
    Prog Biophys Mol Biol; 2014; 116(2-3):101-12. PubMed ID: 25175337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process of Fragment-Based Lead Discovery-A Perspective from NMR.
    Ma R; Wang P; Wu J; Ruan K
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent applications of isotopic labeling for protein NMR in drug discovery.
    Hiroaki H
    Expert Opin Drug Discov; 2013 May; 8(5):523-36. PubMed ID: 23480844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NMR screening in fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Yakugaku Zasshi; 2010 Mar; 130(3):325-33. PubMed ID: 20190517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Solution NMR in Drug Discovery.
    Shi L; Zhang N
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33499337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein NMR-based screening in drug discovery.
    Zartler ER; Shapiro MJ
    Curr Pharm Des; 2006; 12(31):3963-72. PubMed ID: 17100607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach.
    Ziarek JJ; Peterson FC; Lytle BL; Volkman BF
    Methods Enzymol; 2011; 493():241-75. PubMed ID: 21371594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR screening in drug discovery.
    Moore JM
    Curr Opin Biotechnol; 1999 Feb; 10(1):54-8. PubMed ID: 10047510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of (19)F-NMR in Fragment-Based Drug Discovery.
    Norton RS; Leung EW; Chandrashekaran IR; MacRaild CA
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
    Dalvit C; Vulpetti A
    J Med Chem; 2019 Mar; 62(5):2218-2244. PubMed ID: 30295487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design.
    Moore J; Abdul-Manan N; Fejzo J; Jacobs M; Lepre C; Peng J; Xie X
    J Synchrotron Radiat; 2004 Jan; 11(Pt 1):97-100. PubMed ID: 14646145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of NMR and molecular docking in structure-based drug discovery.
    Stark JL; Powers R
    Top Curr Chem; 2012; 326():1-34. PubMed ID: 21915777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution NMR Spectroscopy in Target-Based Drug Discovery.
    Li Y; Kang C
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28832542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nuclear magnetic resonance for drug discovery.
    Sillerud LO; Larson RS
    Methods Mol Biol; 2012; 910():195-266. PubMed ID: 22821598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating protein-ligand binding affinity using high-throughput screening by NMR.
    Shortridge MD; Hage DS; Harbison GS; Powers R
    J Comb Chem; 2008; 10(6):948-58. PubMed ID: 18831571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR Reporter Assays for the Quantification of Weak-Affinity Receptor-Ligand Interactions.
    Almeida TB; Panova S; Walser R
    SLAS Discov; 2021 Sep; 26(8):1020-1028. PubMed ID: 33899548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
    Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
    Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.